These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20104483)

  • 1. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N; Hanouneh IA; Lopez R; Zein NN
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K; Miller C; Hirose K; Diago T; Aucejo F; Quintini C; Eghtesad B; Corey R; Yerian L; Lopez R; Zein N; Fung J
    Clin Transplant; 2010; 24(5):701-8. PubMed ID: 20047619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
    J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
    Zimmermann T; Otto C; Hoppe-Lotichius M; Biesterfeld S; Lautem A; Knaak M; Zimmermann A; Barreiros AP; Heise M; Schattenberg JM; Sprinzl MF; Galle PR; Otto G; Schuchmann M
    Transplant Proc; 2009; 41(6):2549-56. PubMed ID: 19715972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.
    Mas V; Maluf D; Archer KJ; Potter A; Suh J; Gehrau R; Descalzi V; Villamil F
    Liver Transpl; 2011 Jul; 17(7):824-35. PubMed ID: 21618696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
    Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
    Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
    Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
    J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.